000 | 01926 a2200481 4500 | ||
---|---|---|---|
005 | 20250517132159.0 | ||
264 | 0 | _c20181231 | |
008 | 201812s 0 0 eng d | ||
022 | _a2472-5560 | ||
024 | 7 |
_a10.1177/2472555216679994 _2doi |
|
040 |
_aNLM _beng _cNLM |
||
100 | 1 | _aScharf, Nathan T | |
245 | 0 | 0 |
_aNovel Chemical Scaffolds for Inhibition of Rifamycin-Resistant RNA Polymerase Discovered from High-Throughput Screening. _h[electronic resource] |
260 |
_bSLAS discovery : advancing life sciences R & D _c03 2017 |
||
300 |
_a287-297 p. _bdigital |
||
500 | _aPublication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't | ||
650 | 0 | 4 |
_aAntitubercular Agents _xpharmacology |
650 | 0 | 4 |
_aAptamers, Nucleotide _xgenetics |
650 | 0 | 4 |
_aBacterial Proteins _xantagonists & inhibitors |
650 | 0 | 4 | _aBiological Assay |
650 | 0 | 4 |
_aDNA-Directed RNA Polymerases _xantagonists & inhibitors |
650 | 0 | 4 | _aDrug Discovery |
650 | 0 | 4 |
_aDrug Resistance, Bacterial _xdrug effects |
650 | 0 | 4 |
_aEscherichia coli _xdrug effects |
650 | 0 | 4 |
_aExtensively Drug-Resistant Tuberculosis _xdrug therapy |
650 | 0 | 4 | _aGene Expression |
650 | 0 | 4 | _aHigh-Throughput Screening Assays |
650 | 0 | 4 | _aHumans |
650 | 0 | 4 | _aMicrobial Sensitivity Tests |
650 | 0 | 4 | _aMutation |
650 | 0 | 4 |
_aMycobacterium tuberculosis _xdrug effects |
650 | 0 | 4 |
_aPlasmids _xchemistry |
650 | 0 | 4 |
_aRifampin _xpharmacology |
650 | 0 | 4 |
_aRifamycins _xpharmacology |
650 | 0 | 4 |
_aSmall Molecule Libraries _xchemistry |
650 | 0 | 4 | _aStructure-Activity Relationship |
700 | 1 | _aMolodtsov, Vadim | |
700 | 1 | _aKontos, Arrin | |
700 | 1 | _aMurakami, Katsuhiko S | |
700 | 1 | _aGarcia, George A | |
773 | 0 |
_tSLAS discovery : advancing life sciences R & D _gvol. 22 _gno. 3 _gp. 287-297 |
|
856 | 4 | 0 |
_uhttps://doi.org/10.1177/2472555216679994 _zAvailable from publisher's website |
999 |
_c26734982 _d26734982 |